OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era
Ofer Amram, Solmaz Amiri, Victoria Panwala, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 6, pp. 722-729
Closed Access | Times Cited: 78
Ofer Amram, Solmaz Amiri, Victoria Panwala, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 6, pp. 722-729
Closed Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e238-e246
Open Access | Times Cited: 57
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e238-e246
Open Access | Times Cited: 57
Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation
Tara Gomes, Tonya Campbell, Sophie A. Kitchen, et al.
JAMA (2022) Vol. 327, Iss. 9, pp. 846-846
Open Access | Times Cited: 70
Tara Gomes, Tonya Campbell, Sophie A. Kitchen, et al.
JAMA (2022) Vol. 327, Iss. 9, pp. 846-846
Open Access | Times Cited: 70
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs
Christopher M. Jones, Wilson M. Compton, Beth Han, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 9, pp. 932-932
Open Access | Times Cited: 61
Christopher M. Jones, Wilson M. Compton, Beth Han, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 9, pp. 932-932
Open Access | Times Cited: 61
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities
Suzan M. Walters, David C. Perlman, Honoria Guarino, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1144-1153
Open Access | Times Cited: 33
Suzan M. Walters, David C. Perlman, Honoria Guarino, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1144-1153
Open Access | Times Cited: 33
Western Journal of Emergency Medicine
Western Journal of Emergency Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 33
Western Journal of Emergency Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 33
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 29
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
Alison E. Adams, Sarin Blawatt, Tianna Magel, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Alison E. Adams, Sarin Blawatt, Tianna Magel, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Comparing methadone policy and practice in France and the US: Implications for US policy reform
Honora Englander, Mathieu Chappuy, Noa Krawczyck, et al.
International Journal of Drug Policy (2024) Vol. 129, pp. 104487-104487
Closed Access | Times Cited: 8
Honora Englander, Mathieu Chappuy, Noa Krawczyck, et al.
International Journal of Drug Policy (2024) Vol. 129, pp. 104487-104487
Closed Access | Times Cited: 8
The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine
Roman Ivasiy, Lynn M. Madden, Anna Meteliuk, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1585-1596
Closed Access | Times Cited: 7
Roman Ivasiy, Lynn M. Madden, Anna Meteliuk, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1585-1596
Closed Access | Times Cited: 7
Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
Alyssa Shell Tilhou, Laura Dague, Brendan Saloner, et al.
JAMA Health Forum (2022) Vol. 3, Iss. 3, pp. e220093-e220093
Open Access | Times Cited: 27
Alyssa Shell Tilhou, Laura Dague, Brendan Saloner, et al.
JAMA Health Forum (2022) Vol. 3, Iss. 3, pp. e220093-e220093
Open Access | Times Cited: 27
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Daniyar Aldabergenov, Laura Reynolds, Jenny Scott, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103877-103877
Open Access | Times Cited: 25
Daniyar Aldabergenov, Laura Reynolds, Jenny Scott, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103877-103877
Open Access | Times Cited: 25
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs
Jaclyn M. W. Hughto, Abigail Tapper, Sabrina S. Rapisarda, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Jaclyn M. W. Hughto, Abigail Tapper, Sabrina S. Rapisarda, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
Eugenia Oviedo‐Joekes, Sophia Dobischok, José Carvajal, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Eugenia Oviedo‐Joekes, Sophia Dobischok, José Carvajal, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021
Bruno Revol, Théo Willeman, Marc Manceau, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2331398-e2331398
Open Access | Times Cited: 14
Bruno Revol, Théo Willeman, Marc Manceau, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2331398-e2331398
Open Access | Times Cited: 14
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic
Robert A. Kleinman, Marcos Sanches
Drug and Alcohol Dependence (2022) Vol. 242, pp. 109703-109703
Open Access | Times Cited: 21
Robert A. Kleinman, Marcos Sanches
Drug and Alcohol Dependence (2022) Vol. 242, pp. 109703-109703
Open Access | Times Cited: 21
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)
David Goodman‐Meza, Steven Shoptaw, Brett Hanscom, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
David Goodman‐Meza, Steven Shoptaw, Brett Hanscom, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
“Sick and tired of being sick and tired”: Exploring initiation of medications for opioid use disorder among people experiencing homelessness
Natalie Swartz, Tatheer Adnan, Flavia C. Peréa, et al.
Journal of Substance Abuse Treatment (2022) Vol. 138, pp. 108752-108752
Closed Access | Times Cited: 19
Natalie Swartz, Tatheer Adnan, Flavia C. Peréa, et al.
Journal of Substance Abuse Treatment (2022) Vol. 138, pp. 108752-108752
Closed Access | Times Cited: 19
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review
Alison E. Adams, Sarin Blawatt, Scott Macdonald, et al.
International Journal of Drug Policy (2023) Vol. 117, pp. 104058-104058
Open Access | Times Cited: 11
Alison E. Adams, Sarin Blawatt, Scott Macdonald, et al.
International Journal of Drug Policy (2023) Vol. 117, pp. 104058-104058
Open Access | Times Cited: 11
Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review
Victoria Panwala, Paul J. Joudrey, Melanie Kowalski, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209086-209086
Open Access | Times Cited: 10
Victoria Panwala, Paul J. Joudrey, Melanie Kowalski, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209086-209086
Open Access | Times Cited: 10
Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses
Rebecca Arden Harris, Judith A. Long, Yuhua Bao, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 6, pp. e231235-e231235
Open Access | Times Cited: 10
Rebecca Arden Harris, Judith A. Long, Yuhua Bao, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 6, pp. e231235-e231235
Open Access | Times Cited: 10
Perceived organizational support for the treatment of opioid use disorder and its association with primary care provider treatment willingness and medication prescribing
Lindsay Y. Dhanani, William C. Miller, Vivian F. Go, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209623-209623
Open Access
Lindsay Y. Dhanani, William C. Miller, Vivian F. Go, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209623-209623
Open Access
Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan
Amanda R. Liberman, Yelena Rozental, Roman Ivasiy, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209640-209640
Closed Access
Amanda R. Liberman, Yelena Rozental, Roman Ivasiy, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209640-209640
Closed Access
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and Hospitalizations
Ryan Cook, Kendra L. Blalock, Sanae El Ibrahimi, et al.
Journal of General Internal Medicine (2025)
Closed Access
Ryan Cook, Kendra L. Blalock, Sanae El Ibrahimi, et al.
Journal of General Internal Medicine (2025)
Closed Access
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opiod use disorder in the United States
Roman Ivasiy, Lynn M. Madden, Kimberly Johnson, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104748-104748
Closed Access
Roman Ivasiy, Lynn M. Madden, Kimberly Johnson, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104748-104748
Closed Access
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines
Md. Belal Hossain, Brenda Carolina Guerra‐Alejos, Megan Kurz, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e095198-e095198
Open Access
Md. Belal Hossain, Brenda Carolina Guerra‐Alejos, Megan Kurz, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e095198-e095198
Open Access
